PCM
ANIP icon

Polaris Capital Management’s ANI Pharmaceuticals ANIP Stock Holding History

Polaris Capital Management’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.29M Hold
15,600
– – 0.12% 79
2026
Q1 		$1.2M Buy
15,600
+5,900
+61% +$461K 0.1% 72
2025
Q4 		$766K Hold
9,700
– – 0.06% 86
2025
Q3 		$889K Buy
+9,700
New +$791K 0.06% 83

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Polaris Capital Management's ANIP Position: Q2 2026 in Review

Polaris Capital Management held its ANI Pharmaceuticals (ANIP) position steady in Q2 2026 at 15,600 shares worth $1.29M. The position accounts for 0.12% of the portfolio, ranked #79.

Polaris Capital Management first reported a position in ANIP in Q3 2025 and has held it in 4 quarters since. 307 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

  • Polaris Capital Management held 15,600 shares of ANI Pharmaceuticals worth $1.29M as of Q2 2026.
  • Polaris Capital Management left its ANI Pharmaceuticals share count unchanged in Q2 2026.
  • ANI Pharmaceuticals made up 0.12% of Polaris Capital Management's portfolio in Q2 2026, its #79 holding.
  • Polaris Capital Management first reported a position in ANI Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 307 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on Polaris Capital Management's 13F filing for Q2 2026, filed 27 Jul 2026.